Vontobel Asset Management’s Edwards Lifesciences EW Stock Holding History

Vontobel Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-291,858	Closed	-$22.8M	–	72
2019 Q3	$22.8M	Sell	291,858 -201,612	-41%	-$14.2M	0.15%	57
2019 Q2	$30.4M	Buy	493,470 +58,557	+13%	+$3.54M	0.23%	54
2019 Q1	$27.7M	Buy	434,913 +12,258	+3%	+$700K	0.22%	53
2018 Q4	$21.6M	Buy	422,655 +52,890	+14%	+$2.68M	0.19%	58
2018 Q3	$21.5M	Buy	369,765 +30,408	+9%	+$1.49M	0.16%	57
2018 Q2	$16.5M	Sell	339,357 -20,115	-6%	-$939K	0.12%	61
2018 Q1	$16.7M	Sell	359,472 -187,908	-34%	-$8.16M	0.12%	56
2017 Q4	$20.6M	Buy	+547,380	New	+$20.1M	0.15%	53

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vontobel Asset Management's EW Position: Q4 2019 in Review

Vontobel Asset Management sold out of Edwards Lifesciences (EW) in Q4 2019, closing a stake of 291,858 shares — an estimated $22.8M sold.

Vontobel Asset Management first reported a position in EW in Q4 2017 and held it in 8 quarters. The position peaked at $30.4M in Q2 2019. 1,092 funds tracked by Wall St. Rank hold EW as of Q4 2019.

Vontobel Asset Management reported no remaining Edwards Lifesciences position as of Q4 2019 after selling out during the quarter.
Vontobel Asset Management sold 291,858 Edwards Lifesciences shares in Q4 2019, an estimated $22.8M.
Vontobel Asset Management first reported a position in Edwards Lifesciences in Q4 2017 and held it in 8 quarters.
Vontobel Asset Management's Edwards Lifesciences position peaked at $30.4M in Q2 2019.
1,092 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2019.

Based on Vontobel Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.